Reuters logo
BRIEF-Morphosys-MOR208 receives orphan drug status from FDA, EMA to treat of cll/sll
May 20, 2014 / 5:42 AM / 4 years ago

BRIEF-Morphosys-MOR208 receives orphan drug status from FDA, EMA to treat of cll/sll

FRANKFURT, May 20 (Reuters) - Morphosys AG : * Says mor208 program to receive orphan drug designation from FDA and ema for

the treatment of cll/sll

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below